Medication-Assisted Treatment for Co-Occurring Disorders: What Middlesex County Residents Need to Know

When someone in Kendall Park or South Brunswick is struggling with both a substance use disorder and a mental health condition — depression, anxiety, PTSD, bipolar disorder — getting the right treatment is complicated. One question families ask repeatedly: does medication-assisted treatment (MAT) actually work, and is it appropriate when mental health is part of the picture?

The short answer is yes. MAT is an evidence-based, FDA-approved approach that combines medication with counseling and behavioral therapies. It is not a shortcut or a substitute for real recovery. For many New Jersey residents managing co-occurring disorders, it is the component of treatment that makes everything else possible. This article explains what MAT is, how it works, when it is appropriate, and how Middlesex County residents can access it.

What Medication-Assisted Treatment Actually Is

MAT uses specific medications, approved by the Food and Drug Administration, to reduce the physical and psychological burden of substance use disorders — particularly opioid use disorder and alcohol use disorder — so that the rest of treatment can work.

The most commonly used MAT medications include:

• Buprenorphine (Suboxone, Subutex): A partial opioid agonist that reduces cravings and withdrawal symptoms without producing the high of full opioids. It can be prescribed in outpatient settings by certified providers.
• Methadone: A long-acting opioid agonist used in opioid treatment programs (OTPs). It requires daily clinic visits and is tightly regulated. Effective for people who have not responded to other approaches.
• Naltrexone (Vivitrol): An opioid antagonist that blocks the euphoric effects of opioids and alcohol. Available as a daily pill or monthly injection. No abuse potential.
• Naloxone: Primarily used for overdose reversal but also included in combination medications like Suboxone to deter misuse.
• Acamprosate and disulfiram: Used for alcohol use disorder. Acamprosate reduces post-acute withdrawal symptoms; disulfiram creates an aversive reaction to alcohol consumption.

These are not interchangeable. The right medication depends on the substance involved, the individual's medical history, and what other psychiatric medications they may already be taking — which is why co-occurring mental health conditions require careful clinical coordination.

Why Co-Occurring Disorders Change the MAT Conversation

Approximately half of people with a substance use disorder also live with at least one mental health condition. In New Jersey, as statewide opioid overdose data and behavioral health surveys consistently show, this overlap is the norm — not the exception.

The clinical term is "co-occurring disorders" or "dual diagnosis." Common combinations seen in Middlesex County and across New Jersey include:

• Opioid use disorder + depression or anxiety
• Alcohol use disorder + PTSD
• Stimulant use disorder + bipolar disorder
• Cannabis use disorder + psychosis or schizophrenia spectrum disorders

When both conditions are present, treating only one typically fails. Someone who gets their opioid use disorder stabilized on buprenorphine but receives no treatment for underlying PTSD is at high risk of relapse — or of switching to a different substance or behavior to manage the same pain. Someone whose depression is treated with antidepressants but whose alcohol use continues will see limited psychiatric benefit because alcohol is a CNS depressant that directly undermines the medication's effect.

MAT, when integrated into a comprehensive dual-diagnosis treatment plan, addresses the physical stabilization piece so that psychiatric treatment can actually reach the person. That is not a small thing. Active withdrawal — the sweating, the insomnia, the bone-deep physical craving — makes it nearly impossible to engage in therapy, process trauma, or build coping skills. MAT removes that barrier.

What the Research Shows

The evidence base for MAT is substantial and not seriously contested in clinical medicine.

For opioid use disorder, buprenorphine and methadone reduce illicit opioid use, decrease overdose deaths, lower rates of infectious disease transmission (HIV, hepatitis C), and improve treatment retention. The Substance Abuse and Mental Health Services Administration (SAMHSA) and the American Society of Addiction Medicine (ASAM) both recommend MAT as a first-line treatment.

For alcohol use disorder, naltrexone reduces the frequency of heavy drinking days and the likelihood of relapse after a period of abstinence. Acamprosate helps people who have already stopped drinking maintain abstinence by reducing the dysphoria and anxiety that accompany early recovery.

Studies specifically looking at co-occurring disorders find that integrated treatment — MAT plus psychiatric medication management plus behavioral therapy — produces better outcomes than sequential or parallel treatment (addressing each condition separately or one after the other). New Jersey's own Division of Mental Health and Addiction Services has integrated dual-diagnosis care into its standards for licensed residential and outpatient programs precisely because the research supports it.

One clarification that matters for families: MAT is not simply trading one addiction for another. Physical dependence on a medication and addiction are not the same thing. Someone stabilized on buprenorphine who takes it as prescribed, attends therapy, and rebuilds their life is not "still using" in any clinically meaningful sense. That framing causes people to refuse effective treatment and costs lives.

Levels of Care and How MAT Fits In

MAT is not limited to any single level of care. Depending on the severity of the substance use disorder, the psychiatric complexity, and the person's living situation and support system, MAT can be delivered across the continuum:

Medically Supervised Withdrawal (Detox): For people with severe physical dependence on opioids or alcohol, detox is often the first step. Medications are used here to manage acute withdrawal safely. This is a medical service, not a treatment program — it stabilizes the body but does not address the underlying disorder.

Residential Treatment: Longer-term residential settings for people with complex co-occurring disorders can incorporate MAT alongside intensive psychiatric care and behavioral therapy. Residents receive medication management, individual and group therapy, and structured daily programming in a 24-hour clinical environment.

Partial Hospitalization Program (PHP): PHP runs five to six hours per day, five days per week, and can support MAT while the person lives at home or in a sober living environment. This level is appropriate for people who are clinically stable but need intensive daily support.

Intensive Outpatient Program (IOP): IOP runs roughly nine to twelve hours per week in multiple sessions. MAT medications can be managed through the program's prescribing clinician or coordinated with a primary care provider or psychiatrist.

Outpatient: Standard outpatient, including individual therapy and psychiatric medication management, is the ongoing maintenance level for many people stable on MAT. In New Jersey, federally qualified health centers (FQHCs) and certified opioid treatment programs provide buprenorphine and methadone on an outpatient basis.

For Middlesex County residents, the appropriate level of care depends on clinical assessment — not on how "bad" someone thinks their situation is. A formal assessment by a licensed clinician is the right starting point.

Common Questions and Concerns

Will MAT interact with my psychiatric medication? Potentially, yes. This is why integrated prescribing — or at minimum close communication between the prescribing psychiatrist and the MAT provider — matters. Certain combinations require monitoring. This is a clinical conversation, not a reason to avoid MAT.

How long does MAT last? There is no universal timeline. SAMHSA recommends that the duration of MAT be determined by clinical need, not arbitrary cutoffs. Some people remain on maintenance medications for years. Others taper off under medical supervision after a period of stability. Decisions about tapering should be made collaboratively with a prescribing clinician — not driven by stigma or insurance pressure.

Is MAT covered by insurance in New Jersey? New Jersey state law requires insurance coverage for substance use disorder treatment, including MAT, under parity with other medical conditions. Medicaid (NJ FamilyCare) covers MAT. If someone is underinsured or uninsured, the New Jersey Division of Mental Health and Addiction Services funds programs with sliding-scale or no-cost options.

My family member refuses MAT because they think it's "cheating." What do I do? Stigma around MAT is real and costs lives. The conversation is worth having directly: the goal of treatment is a stable, functional life, not a particular method of getting there. If someone is open to speaking with a clinician, a behavioral health navigator can help facilitate that conversation.

How to Access Help in Middlesex County, New Jersey

If you or someone you know in Kendall Park, South Brunswick, or elsewhere in Middlesex County is managing a substance use disorder, a mental health condition, or both, these resources connect to care:

NJMentalHealthCares: Call 866-202-4357 — a free information and referral service operated by the NJ Department of Human Services. Navigators help callers identify appropriate treatment options, insurance coverage, and local providers.

Middlesex County Behavioral Health Navigators: Call 732-745-3810 — county-based navigators who help residents find mental health and substance use treatment, connect to community supports, and navigate insurance barriers.

988 Suicide & Crisis Lifeline: Call or text 988 — available 24 hours a day, seven days a week. For anyone in crisis — whether the crisis involves suicidal ideation, acute psychiatric symptoms, or a substance-related emergency — 988 connects to trained counselors who can help.

If you are in immediate danger or witnessing an overdose, call 911. Naloxone (Narcan) is available without a prescription at New Jersey pharmacies and can reverse an opioid overdose while emergency services are in transit.

The decision to seek treatment is not easy. The clinical tools available — including MAT — are effective. Middlesex County residents do not have to navigate this alone.

CONTENT METADATA Site: mentalhealthresidential.org Target keyword: medication-assisted treatment co-occurring disorders New Jersey Secondary keywords: MAT mental health Middlesex County NJ, dual diagnosis treatment New Jersey, buprenorphine co-occurring disorders NJ Recommended meta description: Learn how medication-assisted treatment (MAT) works for co-occurring mental health and substance use disorders — and how Middlesex County, NJ residents can access care. Internal link suggestions: mentalhealthresidential.org/new-jersey/middlesex-county-mental-health-services, mentalhealthresidential.org/learn/levels-of-care, mentalhealthresidential.org/new-jersey/kendall-park-mental-health-services Compliance flags: none